Bionano Genomics Inc reports results for the quarter ended in December - Earnings Summary

Bionano Genomics

10/03/2023 21:59

* Bionano Genomics Inc  BNGO.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of 11 cents per share.
    * Revenue rose 30.4% to $8.22 million from a year ago;
analysts
expected $8.00 million. 
    * Bionano Genomics Inc's reported EPS for the quarter was a
loss
of 13 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bionano Genomics Inc shares had fallen by 14.4% this
quarter.
    * The company reported a quarterly loss of $38.68 million.
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $6.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 10 at 09:59 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.13          Missed
 Sep. 30 2022      -0.11          -0.11          Met
 Jun. 30 2022      -0.09          -0.11          Missed
 Mar. 31 2022      -0.07          -0.11          Missed